# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA4827568 | Binding | Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control | Homo sapiens | 32 | ALA4825714 | single protein format | Scientific Literature | |
2. | ALA4827569 | Binding | Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 0.1 uM by [gamma-33P]-ATP assay relative to control | Homo sapiens | 32 | ALA4825714 | single protein format | Scientific Literature | |
3. | ALA4827570 | Binding | Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity at 0.01 uM by [gamma-33P]-ATP assay relative to control | Homo sapiens | 32 | ALA4825714 | single protein format | Scientific Literature | |
4. | ALA4827571 | Binding | Inhibition of human CAMKK2 using CAMKKtide as substrate assessed as residual activity by [gamma-33P]-ATP assay relative to control | Homo sapiens | 22 | ALA4825714 | single protein format | Scientific Literature | |
5. | ALA4827572 | Binding | Inhibition of wild-type human partial length CAMKK2 (D65 to V471 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control | Homo sapiens | 9 | ALA4825714 | assay format | Scientific Literature | |
6. | ALA4827573 | Binding | Inhibition of wild-type human partial length CAMKK1 (R65 to E414 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control | Homo sapiens | 9 | ALA4825714 | assay format | Scientific Literature | |
7. | ALA4827574 | Binding | Inhibition of wild-type human partial length CDK8 (M1 to T360 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control | Homo sapiens | 3 | ALA4825714 | assay format | Scientific Literature | |
8. | ALA4827576 | Binding | Inhibition of wild-type human partial length JAK3 JH1 catalytic domain (I781 to S1124 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control | Homo sapiens | 3 | ALA4825714 | assay format | Scientific Literature | |
9. | ALA4827578 | Binding | Inhibition of wild-type human partial length CDK11 (M1 to N360 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control | Homo sapiens | 3 | ALA4825714 | assay format | Scientific Literature | |
10. | ALA4827582 | Binding | Inhibition of wild-type human partial length EPHB6 (Q634 to P948 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control | Homo sapiens | 3 | ALA4825714 | assay format | Scientific Literature | |
11. | ALA4827584 | Binding | Inhibition of wild-type human full length CSNK2A2 (M1 to R350 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control | Homo sapiens | 1 | ALA4825714 | assay format | Scientific Literature | |
12. | ALA4827585 | Binding | Inhibition of wild-type human full length CSNK2A1 (M1 to Q391 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control | Homo sapiens | 1 | ALA4825714 | assay format | Scientific Literature | |
13. | ALA4827586 | Binding | Inhibition of wild-type human partial length PIK3CG (S144 to A1102 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control | Homo sapiens | 1 | ALA4825714 | assay format | Scientific Literature | |
14. | ALA4827587 | Binding | Inhibition of wild-type human partial length NEK10 (L488 to R809 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control | Homo sapiens | 1 | ALA4825714 | assay format | Scientific Literature | |
15. | ALA4827588 | Binding | Inhibition of wild-type human partial length CLK2 (D144 to R498 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control | Homo sapiens | 1 | ALA4825714 | assay format | Scientific Literature | |
16. | ALA4827589 | Binding | Inhibition of wild-type human partial length ICK (M1 to P314 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control | Homo sapiens | 2 | ALA4825714 | assay format | Scientific Literature | |
17. | ALA4827590 | Binding | Inhibition of wild-type human partial length GAK (G13 to Y338 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control | Homo sapiens | 1 | ALA4825714 | assay format | Scientific Literature | |
18. | ALA4827591 | Binding | Inhibition of wild-type human partial length TYK2 JH1 catalytic domain (V877 to C1187 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control | Homo sapiens | 1 | ALA4825714 | assay format | Scientific Literature | |
19. | ALA4827592 | Binding | Inhibition of wild-type human partial length CAMKK2 (D65 to V471 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control | Homo sapiens | 1 | ALA4825714 | assay format | Scientific Literature | |
20. | ALA4827593 | Binding | Inhibition of wild-type human partial length CAMKK1 (R65 to E414 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control | Homo sapiens | 1 | ALA4825714 | assay format | Scientific Literature |